Cheng Xie

Cheng Xie

Auto-generated profile, based on publicly available information

Cheng Xie

Key Laboratory of Medical Electrophysiology of the Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease, Institute of Cardiovascular Research, Public Center of Experimental Technology, Hemodynamics and Medical Engineering Combination Key Laboratory of Luzhou, Southwest Medical University, China (H.T., X.L., C.X., X.Z., Y.Y., P.L., C. Li, J.C.).

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Hypertension
Verified
Journal Article
Closed access
HTHai Tian
Hai Tian
XLXin Liao
Xin Liao
CXCheng Xie
Cheng Xie
XZXiaolin Zhang
Xiaolin Zhang
GRGuoqiang Ren
Guoqiang Ren
JCJun Cheng
Jun Cheng
BACKGROUND: Mechanisms of endothelial repair in hypertension remain unclear. CD34 + cells are reported to contribute to vascular regeneration; however, their origin and regulation in hypertension are poorly understood. We investigated the role of IK Ca channels in CD34 + cell-mediated endothelial repair during Ang II (angiotensin II)-induced arteriole remodeling. METHODS: Using inducible lineage tracing (Cd34-CreERT2; R26-tdTomato), we tracked nonbone marrow-derived CD34 + cells in hypertensive mice. Single-cell RNA sequencing, immunofluorescence, transwell migration assays, and patch-clamp techniques were used to analyze phenotypic transitions, ion channel activity, and signaling pathways. Bone marrow transplantation, the IK Ca channel inhibitor TRAM-34, and the ERK (extracellular signal-regulated kinase) inhibitor PD98059 were used to validate functional mechanisms. RESULTS: Lineage tracing revealed that nonbone marrow-derived CD34 + cells contributed to endothelial repair under hypertensive conditions. Immunofluorescence analysis showed an increase in CD31 + -tdTomato + cells in the arterioles of Ang II-treated mice after 6 weeks, indicating improved endothelial integrity. Single-cell RNA sequencing revealed 2 subgroups of endothelial cells, one of which expressed stem cell markers such as CD34 (cluster of differentiation 34), Flk-1 (fetal liver kinase 1), and Sca-1 (stem cell antigen-1). Gene expression analysis showed that CD34 + cells are involved in endothelial repair through the regulation of cell migration. Importantly, IK Ca channel activation facilitated CD34 + cell migration, and TRAM-34-based inhibition of IK Ca channels reduced migration. Mechanistic studies revealed that Ang II enhanced CD34 + cell migration via IK Ca -mediated activation of the ERK/P38 signaling pathway, promoting cytoskeletal reorganization and increased intracellular calcium levels. CONCLUSIONS: Arteriole-resident CD34 + cells contribute to endothelial repair in Ang II-induced hypertension. Moreover, IK Ca channel upregulation facilitates CD34 + cell migration via ERK/P38 signaling, suggesting potential therapeutic targets for hypertension.